Susquehanna International Group’s MediciNova MNOV Stock Holding History

Susquehanna International Group’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,700	Closed	-$22.4K	–	12935
2023 Q3	$22.4K	Sell	10,700 -4,600	-30%	-$10.7K	﹤0.01%	11573
2023 Q2	$35.2K	Buy	+15,300	New	+$33.7K	﹤0.01%	11468
2022 Q1	–	Sell	-14,800	Closed	-$40K	–	13607
2021 Q4	$40K	Sell	14,800 -22,900	-61%	-$76.5K	﹤0.01%	12660
2021 Q3	$143K	Buy	37,700 +14,200	+60%	+$54K	﹤0.01%	11828
2021 Q2	$100K	Sell	23,500 -18,300	-44%	-$78.8K	﹤0.01%	12099
2021 Q1	$211K	Sell	41,800 -18,000	-30%	-$105K	﹤0.01%	11330
2020 Q4	$315K	Buy	+59,800	New	+$343K	﹤0.01%	9160
2018 Q3	–	Sell	-10,300	Closed	-$82K	–	9852
2018 Q2	$82K	Buy	+10,300	New	+$106K	﹤0.01%	9123
2017 Q1	–	Sell	-10,800	Closed	-$65K	–	9566
2016 Q4	$65K	Buy	+10,800	New	+$76.1K	﹤0.01%	9222

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group's MNOV Position: Q1 2026 in Review

Susquehanna International Group increased its MediciNova (MNOV) stake by 93% in Q1 2026, buying an estimated $32.1K and bringing the position to 43,926 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #12580.

Susquehanna International Group first reported a position in MNOV in Q1 2016 and has held it in 27 quarters since. The position peaked at $771K in Q1 2016. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

Susquehanna International Group held 43,926 shares of MediciNova worth $60.2K as of Q1 2026.
Susquehanna International Group bought 21,173 MediciNova shares in Q1 2026, an estimated $32.1K.
MediciNova made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12580 holding.
Susquehanna International Group first reported a position in MediciNova in Q1 2016 and has held it in 27 quarters since.
Susquehanna International Group's MediciNova position peaked at $771K in Q1 2016.
30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.